Your session is about to expire
← Back to Search
Survivorship Care for Breast Cancer Survivors
N/A
Waitlist Available
Led By Kimlin Ashing-Giwa
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 12 months
Awards & highlights
Study Summary
This trial is testing whether survivorship care planning can help improve the quality of life in breast cancer survivors. Early results suggest it may reduce stress and improve well-being.
Who is the study for?
This trial is for breast cancer survivors living in Southern California who are post-surgery up to 18 months after active treatment for stage 0-3 breast cancer. It's open to those with a history of mild depression, anxiety, hypertension, or diabetes.Check my eligibility
What is being tested?
The study tests if survivorship care plans can improve life quality for breast cancer survivors. Participants will receive educational and counseling interventions alongside standard care and complete questionnaires assessing their well-being.See study design
What are the potential side effects?
Since the interventions involve education and counseling rather than medications, there may be minimal side effects such as emotional distress or discomfort during discussions about personal experiences with cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Adherence to SCP guidelines
Proportion of BCS accessing a SCP from their oncology provider
Other outcome measures
Develop a clinically and psychosocially responsive SCP-BCS template in English and a linguistically response bilingual version (English-Spanish)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (SCP-BCS template booklet and counseling)Experimental Treatment4 Interventions
Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.
Group II: Arm II (SCP-BCS template booklet)Active Control4 Interventions
Participants receive SCP-BCS template booklet and receive standard follow-up care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
quality-of-life assessment
2012
Completed Phase 3
~2780
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,567 Total Patients Enrolled
939 Trials studying Breast Cancer
1,543,260 Patients Enrolled for Breast Cancer
City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,360 Total Patients Enrolled
42 Trials studying Breast Cancer
6,549 Patients Enrolled for Breast Cancer
Kimlin Ashing-GiwaPrincipal InvestigatorCity of Hope Medical Center
2 Previous Clinical Trials
195 Total Patients Enrolled
1 Trials studying Breast Cancer
145 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You live in Southern California.You have been treated for stage 0-3 breast cancer within the last 18 months.
Research Study Groups:
This trial has the following groups:- Group 1: Arm I (SCP-BCS template booklet and counseling)
- Group 2: Arm II (SCP-BCS template booklet)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there an ongoing opportunity to join this clinical experiment?
"As per information available on clinicaltrials.gov, the recruitment process for this medical trial has temporarily ceased as of February 17th 2022 after being first posted on July 15th 2013. Nevertheless there are still 2622 other trials that have open enrollments at present."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger